As a consequence, we supposed that the hypermethylation of the P1 KEAP1 promoter might lead to the loss of SP-1 and AP-2 binding via inhibiting its expression at the first two, 4th and 5th CpG sites in the analyzed lung cancer cells, respectively [29,40]. This evidence concerns the gene SP1 and lung cancer.